-+ 0.00%
-+ 0.00%
-+ 0.00%

Intellia Therapeutics Files Initial Beneficial Ownership Statement for EVP, Chief Medical Officer Jing L. Marantz

PUBT·10/28/2026 20:17:10
Intellia Therapeutics Files Initial Beneficial Ownership Statement for EVP, Chief Medical Officer Jing L. Marantz
  • Intellia Therapeutics filed an initial beneficial ownership statement for Jing L. Marantz, executive vice president and chief medical officer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-436123), on October 28, 2026, and is solely responsible for the information contained therein.